| __timestamp | Verona Pharma plc | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4101058 | 293000 |
| Thursday, January 1, 2015 | 10763215 | 1002000 |
| Friday, January 1, 2016 | 5579049 | 888000 |
| Sunday, January 1, 2017 | 32051299 | 19623000 |
| Monday, January 1, 2018 | 24482286 | 30421000 |
| Tuesday, January 1, 2019 | 43892589 | 34794000 |
| Wednesday, January 1, 2020 | 44505000 | 28304000 |
| Friday, January 1, 2021 | 79406000 | 56886000 |
| Saturday, January 1, 2022 | 49283000 | 100894000 |
| Sunday, January 1, 2023 | 17282730 | 159765000 |
Unlocking the unknown
In the dynamic world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Verona Pharma plc and Viridian Therapeutics, Inc. have been at the forefront of this race, each investing significantly in R&D to drive breakthroughs.
From 2014 to 2023, Verona Pharma's R&D expenses surged by over 300%, peaking in 2021 with a remarkable 79 million USD. Meanwhile, Viridian Therapeutics demonstrated an even more aggressive growth trajectory, with a staggering 54,000% increase, culminating in 2023 with an investment of nearly 160 million USD.
This data not only highlights the commitment of these companies to innovation but also underscores the competitive nature of the pharmaceutical industry. As they continue to push boundaries, the future of healthcare looks promising, with potential breakthroughs on the horizon.
Research and Development Investment: Merck & Co., Inc. vs Viridian Therapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Viridian Therapeutics, Inc.
R&D Insights: How Bristol-Myers Squibb Company and Verona Pharma plc Allocate Funds
Comparing Innovation Spending: BeiGene, Ltd. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Verona Pharma plc
R&D Spending Showdown: Exelixis, Inc. vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
Research and Development Expenses Breakdown: Grifols, S.A. vs Verona Pharma plc
R&D Insights: How Verona Pharma plc and Xenon Pharmaceuticals Inc. Allocate Funds
Comparing Innovation Spending: Verona Pharma plc and Protagonist Therapeutics, Inc.
R&D Insights: How Perrigo Company plc and Viridian Therapeutics, Inc. Allocate Funds
Vericel Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?